Welcome to our dedicated page for Agronomics news (Ticker: AGNMF), a resource for investors and traders seeking the latest updates and insights on Agronomics stock.
Agronomics Limited (AGNMF) is a London-listed investment company focused on clean food and cellular agriculture, and its news flow reflects activity across a portfolio of more than 20 private companies in this emerging field. Company announcements cover new investments, follow-on funding, portfolio milestones and periodic updates on net asset value, giving readers insight into how Agronomics is deploying capital and how its holdings are progressing.
Recent news has highlighted additional investments in precision fermentation businesses, such as funding for All G Co Holdings Pty Limited, which develops human and bovine milk proteins like lactoferrin without the use of animals. Agronomics has also reported further equity investment in BlueNalu, Inc., a cell-cultivated seafood company working on products such as cultivated bluefin tuna toro for premium foodservice markets.
Updates on other portfolio companies include Liberation Bioindustries, which is building a commercial-scale precision fermentation facility to produce bio-based protein and other ingredients, Geltor, Inc., which has received an FDA “no questions” letter confirming GRAS status for its vegan collagen polypeptide PrimaColl, Clean Food Group Limited, which manufactures sustainable oils and fats through fermentation, and Onego Bio, whose precision-fermented egg protein Bioalbumen has also received an FDA GRAS “no questions” letter.
News items may also cover less favourable developments, such as the dissolution of Meatable B.V., and periodic net asset value calculations that summarise the impact of portfolio movements and foreign exchange changes on Agronomics’ balance sheet. For investors and observers interested in cellular agriculture and alternative proteins, the Agronomics news stream provides regular, company-sourced updates on financing rounds, regulatory progress and commercial partnerships across this specialised investment portfolio.
Agronomics Limited (AGNMF) reported its unaudited Net Asset Value (NAV) as of March 31, 2025, at 14.81 pence per share, representing a 0.80% decrease from December 2024. The company's Net Assets stand at £149 million, including £146 million in investments and £4 million in cash. The current share price of 7.15 pence represents a 52% discount to NAV.
Key portfolio developments include: Liberation Labs securing a $50.5M convertible note raise, Formo Bio obtaining a €35M EIB loan, and Solar Foods receiving €10M in government funding. Notable milestone: Good Dog Food (Meatly) became the first company to sell cultivated meat for pet food in Europe. The quarter saw a £1.2M NAV decline, mainly due to FX losses of £2.5M, partially offset by a £1.3M value increase in Solar Foods holding.
Agronomics (LSE:ANIC) announces a strategic collaboration between its portfolio company Meatable and TruMeat to advance cultivated meat commercialization. Meatable, a cultivated meat technology leader, will partner with TruMeat, a contract manufacturer, to build a state-of-the-art facility in Singapore using Meatable's technology.
The collaboration aims to optimize processes and media development to produce cultivated meat at competitive price points and commercial scale. Agronomics has invested €9.2 million in Meatable, currently valued at £11.4 million, representing approximately 7.5% of Agronomics' last stated Net Asset Value as of December 31, 2024.
The new facility will be Singapore's first to deliver cultivated meat at cost levels and volumes needed for commercial partners to formulate, test, and launch products in the market.
Agronomics announces the expansion of its portfolio company BlueNalu's partnership with Nomad Foods to commercialize cell-cultivated seafood in the UK and Europe. The partnership, first established in 2021, will focus on market entry through premium foodservice channels.
BlueNalu has joined the UK Food Standards Agency's regulatory program as the only company focused on cell-cultivated seafood. Recent research shows strong consumer interest, with 92% of UK sushi consumers eager to try BlueNalu's first commercial product, cell-cultivated bluefin tuna toro. Notably, 74% of consumers expressed willingness to pay the same or higher prices compared to conventional bluefin tuna.
Agronomics has invested US$8.0 million in BlueNalu, currently valued at £13.0 million, representing approximately 8.6% of Agronomics' Net Asset Value as of December 2024.
Agronomics (LSE:ANIC), a leading clean food company, has announced that an advisory consultant to Shellbay Investments has exercised nil paid options over 2,289,549 shares. The shares will be transferred immediately from Shellbay, which is indirectly owned by Jim Mellon, the Executive Chair of Agronomics.
Following this transaction, Shellbay now holds 24,097 Ordinary Shares, all of which remain subject to the 2024 Options. The company's total issued share capital remains unchanged at 1,009,417,295 ordinary shares with a nominal value of £0.000001.
Post-transaction, Jim Mellon maintains interest in 158,117,002 Ordinary Shares, with 152,710,944 held by Galloway , 24,097 by Shellbay, and 5,381,961 held directly. Richard Reed holds interest in 6,354,412 Ordinary Shares through Reepa
Agronomics (AGNMF), a leading investor in clean food, announced that all resolutions were passed at their Annual General Meeting (AGM) held on February 7, 2025. The announcement was made through the London Stock Exchange's news service, RNS, which is approved by the Financial Conduct Authority as a Primary Information Provider in the United Kingdom.
Agronomics (LSE:ANIC) announces that its portfolio company Meatly has launched the world's first cultivated meat dog treat, marking the first sale of cultivated meat in Europe. The 'Chick Bites' treats, produced in collaboration with THE PACK, will be available at Pets at Home Brentford, London from February 7, 2025, priced at £3.49 for 50g pouches with approximately 750 units available.
Meatly Chicken is produced from cells taken from a chicken egg and contains essential nutrients for pet health. The company plans to expand production in the next 3-5 years. Agronomics has invested £1.2 million in Meatly, currently valued at £4.5 million, representing 2.9% of Agronomics' Net Asset Value with a 25.54% equity ownership.
The pet food market is growing at 7% annually and is expected to reach £120 billion by 2026. In the UK, pets consume 22% of meat, significantly impacting environmental resources.
Agronomics (LSE:ANIC), a leading company in clean food investments, announced that Executive Chair Jim Mellon has increased his stake in the company through an indirect purchase. Galloway , wholly owned by Mellon, acquired 1,300,000 shares at 3.80 pence per share on February 4, 2025, for a total investment of £49,400.
Following this transaction, Mellon's total interest in the company stands at 160,406,551 Ordinary Shares, representing 15.89% of the total issued capital. This holding is distributed across Galloway (152,710,944 shares), Shellbay Investments (2,313,646 shares), and direct ownership (5,381,961 shares).
Agronomics maintains a portfolio of over 20 companies in the clean food sector, focusing on technologies that offer new ways of producing food and materials traditionally derived from animals.
Agronomics (AIM:ANIC) reports its unaudited Net Asset Value (NAV) as of December 31, 2024, at 14.93 pence per share, marking a 5.21% decrease from 15.73 pence in September 2024. Net Assets stand at £151 million, comprising £141 million in investments and £10 million in cash.
The company experienced a £8.1 million NAV decline during the quarter, primarily due to: a £4.3 million reduction in Solar Foods Oy value, a £4.3 million unrealized FX gain, a significant £6.8 million write-down of Geltor Inc following a 95% discounted funding round, and a £0.9 million reversal of unrealized gain on CellX
Notable developments include Liberation Labs securing US$50.5 million in total funding and All G receiving regulatory clearance for recombinant bovine lactoferrin sales in China. The company's share price of 3.88 pence represents a 74% discount to NAV, with no intention to raise capital while trading at a discount.
FAQ
What is the current stock price of Agronomics (AGNMF)?
What is the market cap of Agronomics (AGNMF)?
